
Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients,
Author(s) -
Ghosn
Publication year - 2003
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-200317004-00022
Subject(s) - cmin , indinavir , cmax , regimen , ritonavir , medicine , tolerability , pharmacokinetics , viral load , immunology , human immunodeficiency virus (hiv) , adverse effect , antiretroviral therapy